Search research articles
Contact Us
Filters
Showing results (71-80 of 209) with videos related to
Page
of 21
Sort By:
Journal of the American Academy of Dermatology
|
August 19, 2015
Annual screening for tuberculosis in patients on TNF-alfa antagonists
Sean D Doherty, Mark G Lebwohl, Abby S Van Voorhees, et al.
Journal of the American Academy of Dermatology
|
June 12, 2020
No reactivation of tuberculosis in patients with latent tuberculosis infection receiving ixekizumab: A report from 16 clinical studies of patients with psoriasis or psoriatic arthritis
Ulrich Mrowietz, Elisabeth Riedl, Stefan Winkler, et al.
Dermatology and Therapy
|
August 2, 2021
Long-Term Proactive Treatment of Plaque Psoriasis with Calcipotriene/Betamethasone Dipropionate Foam Prolongs Remission and Reduces Relapses Irrespective of Patient Baseline Characteristics
Mark G Lebwohl, Kim A Papp, Marie Holst Mørch, et al.
Dermatology and Therapy
|
December 18, 2021
Impact of Risankizumab on PASI90 and DLQI0/1 Duration in Moderate-to-Severe Psoriasis: A Post Hoc Analysis of Four Phase 3 Clinical Trials
Mark G Lebwohl, Ahmed M Soliman, Hongbo Yang, et al.
Journal of Drugs in Dermatology : JDD
|
August 7, 2025
Resolving Hyperkeratotic Psoriasis: Mechanisms of Action and Additive Effects of Fixed-Combination Halobetasol Propionate and Tazarotene
Emil A Tanghetti, Mark G Lebwohl, Linda Stein Gold, et al.
Journal of the American Academy of Dermatology
|
November 4, 2020
Risk of skin disorders in patients with celiac disease: A population-based cohort study
Benjamin Lebwohl, Jonas Söderling, Bjorn Roelstraete, et al.
The British Journal of Dermatology
|
January 4, 2022
Evaluating the role of histopathology in diagnosing pyoderma gangrenosum using Delphi and PARACELSUS criteria: a multicentre, retrospective cohort study
Michelle S Min, Kylee Kus, Nancy Wei, et al.
Archives of Dermatological Research
|
August 30, 2024
Interleukin-1α inhibitor bermekimab in patients with atopic dermatitis: randomized and nonrandomized studies
Eric L Simpson, Emma Guttman-Yassky, Jeffrey Pawlikowski, et al.
Journal of Drugs in Dermatology : JDD
|
September 28, 2010
A randomized, double-blinded, placebo-controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic keratoses
Joseph L Jorizzo, Orit Markowitz, Mark G Lebwohl, et al.
Journal of Drugs in Dermatology : JDD
|
December 5, 2013
Clinical study results of desoximetasone spray, 0.25% in moderate to severe plaque psoriasis
Leon Kircik, Mark G Lebwohl, James Q Del Rosso, et al.
Page
of 21
Search research articles
Search
Showing results (71-80 of 209) with videos related to
Sort By:
Page
of 21
Journal of the American Academy of Dermatology
|
August 19, 2015
Annual screening for tuberculosis in patients on TNF-alfa antagonists
Sean D Doherty, Mark G Lebwohl, Abby S Van Voorhees, et al.
Journal of the American Academy of Dermatology
|
June 12, 2020
No reactivation of tuberculosis in patients with latent tuberculosis infection receiving ixekizumab: A report from 16 clinical studies of patients with psoriasis or psoriatic arthritis
Ulrich Mrowietz, Elisabeth Riedl, Stefan Winkler, et al.
Dermatology and Therapy
|
August 2, 2021
Long-Term Proactive Treatment of Plaque Psoriasis with Calcipotriene/Betamethasone Dipropionate Foam Prolongs Remission and Reduces Relapses Irrespective of Patient Baseline Characteristics
Mark G Lebwohl, Kim A Papp, Marie Holst Mørch, et al.
Dermatology and Therapy
|
December 18, 2021
Impact of Risankizumab on PASI90 and DLQI0/1 Duration in Moderate-to-Severe Psoriasis: A Post Hoc Analysis of Four Phase 3 Clinical Trials
Mark G Lebwohl, Ahmed M Soliman, Hongbo Yang, et al.
Journal of Drugs in Dermatology : JDD
|
August 7, 2025
Resolving Hyperkeratotic Psoriasis: Mechanisms of Action and Additive Effects of Fixed-Combination Halobetasol Propionate and Tazarotene
Emil A Tanghetti, Mark G Lebwohl, Linda Stein Gold, et al.
Journal of the American Academy of Dermatology
|
November 4, 2020
Risk of skin disorders in patients with celiac disease: A population-based cohort study
Benjamin Lebwohl, Jonas Söderling, Bjorn Roelstraete, et al.
The British Journal of Dermatology
|
January 4, 2022
Evaluating the role of histopathology in diagnosing pyoderma gangrenosum using Delphi and PARACELSUS criteria: a multicentre, retrospective cohort study
Michelle S Min, Kylee Kus, Nancy Wei, et al.
Archives of Dermatological Research
|
August 30, 2024
Interleukin-1α inhibitor bermekimab in patients with atopic dermatitis: randomized and nonrandomized studies
Eric L Simpson, Emma Guttman-Yassky, Jeffrey Pawlikowski, et al.
Journal of Drugs in Dermatology : JDD
|
September 28, 2010
A randomized, double-blinded, placebo-controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic keratoses
Joseph L Jorizzo, Orit Markowitz, Mark G Lebwohl, et al.
Journal of Drugs in Dermatology : JDD
|
December 5, 2013
Clinical study results of desoximetasone spray, 0.25% in moderate to severe plaque psoriasis
Leon Kircik, Mark G Lebwohl, James Q Del Rosso, et al.
Page
of 21